FIELD: medicine.
SUBSTANCE: medication for treatment and prevention of asthma contains FGF2 (fibroblast growth factor-2) as active ingredient, asthma being caused by overexpression of IL-13 (interleikin-13) or overexpression of IFN-γ (interferon-γ), where FGF2 inhibits IL-13 activity, FGF2 inhibits VEGF activity and FGF2 inhibits TGF-β1 activity (transforming growth factor-β1). Medication for treatment or prevention of chronic obstructive lung disease (COLD), containing FGF2 (fibroblast growth factor-2) as active ingredient, where chronic obstructive lung disease (COLD) is caused by overexpression of IFN-γ (interferon-γ). Inhibitor of IL-13 activity, containing FGF2 (fibroblast growth factor-2) as active ingredient. Inhibitor of VEGF activity, containing FGF2 (fibroblast growth factor-2) as active ingredient. Inhibitor of TGF-β1 activity, containing FGF2 (fibroblast growth factor-2) as active ingredient.
EFFECT: prevention of asthma and COLD.
8 cl, 31 dwg, 7 ex
